Relationship between double COVID-19 vaccine uptake and trust in effectiveness and safety of vaccination in general in 23 Member states of the European Union: an ecological study.
COVID-19
European Union
Vaccination
Vaccine effectiveness
Vaccine safety
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
30 07 2022
30 07 2022
Historique:
received:
04
06
2021
revised:
09
06
2022
accepted:
19
06
2022
pubmed:
8
7
2022
medline:
22
7
2022
entrez:
7
7
2022
Statut:
ppublish
Résumé
The aim of this study was to assess the relationship between double COVID-19 vaccine uptake and trust in effectiveness and safety of vaccination in general in 23 European Union (EU) countries. Ecological study. Data was retrieved from the Flash Eurobarometer 494 and Our World in Data. We estimated Pearson's correlation coefficients and fitted multiple linear regression models. There is a negative linear correlation between the percentage of people doubly vaccinated and the percentage of low trust in vaccine effectiveness (r = -0.48, p-value = 0.021), and the percentage of low trust in vaccine safety (r = -0.43, p-value = 0.041). There is a negative adjusted relation between the percentage of low trust in vaccine safety and the percentage of people doubly vaccinated (aβ An increase in health literacy of people living in certain countries in the EU may be needed to boost COVID-19 vaccine uptake.
Identifiants
pubmed: 35798592
pii: S0264-410X(22)00820-9
doi: 10.1016/j.vaccine.2022.06.049
pmc: PMC9222347
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
4334-4338Informations de copyright
Copyright © 2022 Elsevier Ltd. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Vaccines (Basel). 2021 Feb 16;9(2):
pubmed: 33669441
Euro Surveill. 2018 Apr;23(17):
pubmed: 29717694
Pharm Pract (Granada). 2021 Jan-Mar;19(1):2276
pubmed: 33828622
Lancet. 2021 May 15;397(10287):1783-1785
pubmed: 33964221
Immunity. 2020 May 19;52(5):737-741
pubmed: 32433946
Infect Dis Rep. 2021 May 14;13(2):429-436
pubmed: 34069242
Lancet Public Health. 2021 Apr;6(4):e210-e221
pubmed: 33556325
Pers Individ Dif. 2021 Apr;172:110590
pubmed: 33518869
Gac Sanit. 2018 Nov - Dec;32(6):590-591
pubmed: 28928057
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
Vaccines (Basel). 2021 Feb 18;9(2):
pubmed: 33670621